Vera Therapeutics, Inc. (VERA)

NASDAQ: VERA · IEX Real-Time Price · USD

34.65

-0.17 (-0.49%)

At close: Jul 19, 2024, 4:00 PM

34.66

+0.01 (0.03%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Vera Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Selling, General & Admin	25.55	23.79	21.91	11.92	4.04	4.41
Research & Development	76.32	78.23	68.99	22.48	45.21	7.29
Other Operating Expenses	0	0	0	0	3	0.26
Operating Expenses	101.87	102.01	90.9	34.4	52.24	11.96
Operating Income	-101.87	-102.01	-90.9	-34.4	-52.24	-11.96
Interest Expense / Income	4.82	3.79	0.99	0.02	0.17	0.05
Other Expense / Income	-12.38	-9.81	-2.84	-1.81	1.01	-0.16
Pretax Income	-94.3	-95.99	-89.06	-32.61	-53.41	-11.85
Income Tax	0	0	0	0	0	0
Net Income	-94.3	-95.99	-89.06	-32.61	-53.41	-11.85
Shares Outstanding (Basic)	51	43	27	13	0	0
Shares Outstanding (Diluted)	51	43	27	13	0	0
Shares Change	35.32%	60.73%	97.76%	4099.14%	8.34%	-
EPS (Basic)	-2.05	-2.25	-3.35	-2.43	-166.93	-40.14
EPS (Diluted)	-2.05	-2.25	-3.35	-2.43	-166.93	-40.14
Free Cash Flow	-99.78	-92.24	-67.66	-23.71	-34.85	-10.41
Free Cash Flow Per Share	-1.96	-2.16	-2.55	-1.76	-108.92	-35.26
EBITDA	-92.37	-94.07	-86.64	-32.41	-53	-11.29
Depreciation & Amortization	-2.89	-1.86	1.43	0.18	0.25	0.51
EBIT	-89.48	-92.2	-88.06	-32.59	-53.25	-11.8

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).